COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

Piper Sandler 32nd Annual Healthcare Conference

Nov 23, 2020

Southwest IDEAS Investor Conference

Nov 18, 2020 at 8:00 AM EST

Listen to webcast

November Investor Presentation

Nov 17, 2020

Supporting Materials

View Presentation 1 MB

BDSI Third Quarter 2020 Financial Results Call and Webcast

Nov 5, 2020 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 601.9 KB

Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2020 at 11:20 AM EDT

Listen to webcast

H.C. Wainwright 22nd Annual Global Investor Conference

Sep 14, 2020 at 12:30 PM EDT

Listen to webcast

BDSI Second Quarter 2020 Financial Results Call and Webcast

Aug 5, 2020 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 662.8 KB

William Blair 40th Annual Growth Stock Conference

Jun 11, 2020 at 9:40 AM EDT

Listen to webcast

Jefferies Virtual Healthcare Conference

Jun 2, 2020 at 3:00 PM EDT

Listen to webcast

Supporting Materials

View Presentation 1.3 MB

Recent BDSI News

BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting January 15, 2021

Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA ® to Oxycodone on January 16 from 1:10pm – 2:10pm CT RALEIGH, N.C. , Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty ...

BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference November 20, 2020

RALEIGH, N.C. , Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeff Bailey , Chief Executive Officer, and ...

BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18 November 11, 2020

RALEIGH, N.C. , Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey , Chief Executive Officer, and ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now